To further clarify the expression of LAS1L exon 9 in NSCLC clinical samples, a total of 58 samples including 29 NSCLC tumor samples and 29 corresponding normal samples were randomly selected from the specimen bank. This evidence concerns the gene LAS1L and non-small cell lung carcinoma.